Craig Wichner was named Chief Executive Officer of Cibus, Inc., succeeding Peter Beetham. As of November 6, 2026, Cibus, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from April 10, 2026 to June 9, 2026, naming 2 appointments and 2 departures (Form 8-K, June 9, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Cibus, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Cibus, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-10 to 2026-06-09. They name 3 people, with 2 appointments and 2 departures. Every row below is cited to the filing it comes from, and this page adds each new change as Cibus, Inc. files it.
Also on the record for Cibus, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| May 6, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 15% of the class | 5%+ stakes | Source |
| February 5, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 13.9% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 4.99% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Cibus, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Cibus, Inc. and the records around it.
Cibus, Inc. elsewhere on the record
Companies that share a holder
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
Watch Cibus, Inc.
Get an email when Cibus, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Cibus, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Cibus, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cibus, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-09 | In | Chief Executive Officer | 8-K, 2026-06-09 | ||
| 2026-06-09 | Out | 8-K, 2026-06-09 | |||
| 2026-06-09 | Out | Chief Executive Officer | 2026-06-08 | 8-K, 2026-06-09 | |
| 2026-04-10 | In | Director | 8-K, 2026-04-10 |
Who leads Cibus, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Craig Wichner, appointed (filed 2026-06-09).
- Director: Thomas Urban, appointed (filed 2026-04-10).
New leaders reset buying decisions — get the Full Report on Cibus, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Executive Officer at Cibus, Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Cibus, Inc.Every change, in the filing's words
Appointed: Craig Wichner, Chief Executive Officer
As the culmination of its previously announced succession planning strategy, the Board of Directors (the "Board") of Cibus, Inc. (the "Company") appointed Craig Wichner as the Company's Chief Executive Officer on June 8, 2026.
Departing: Craig Wichner
Concurrently with the appointment, Mr. Wichner resigned from the Board and from the Strategy Committee of the Board.
Departing: Peter Beetham, Chief Executive Officer, effective 2026-06-08
To facilitate the Chief Executive Officer transition and related Board transition designed to enhance the independence of the Board, Dr. Beetham resigned from the Board also effective June 8, 2026.
- Mr. Wichner joined the Company's Board in November 2025.
- Mr. Wichner, age 56, is the Founder and Managing Partner of Farmland LP ("Farmland"), a leading United States farmland investment management firm with more than $350 million in assets and over 19,000 acres under management.
- Mr. Wichner founded Farmland in 2009 to demonstrate that organic and regenerative farmland management can enhance both soil health and long-term investment performance.
- Prior to founding Farmland, Mr. Wichner founded and managed several technology and investment companies focused on data-driven business models and sustainable growth.
- Mr. Wichner previously served on the Board of Directors of BN Ranch, the successor company to Niman Ranch, which was acquired by Blue Apron Holdings, Inc. (NYSE: APRN).
- Mr. Wichner also manages private family real estate holdings.
- Mr. Wichner holds a Bachelor of Science degree in Biochemistry and Molecular Biology with a minor in Economics from the University of California, San Diego.
- On June 8, 2026, Peter Beetham, who had been serving as Interim Chief Executive Officer since February 2025, returned to his role as the Company's President and Chief Operating Officer.
- Dr. Beetham has served as the Company's President and Chief Operating Officer since June 2023.
Appointed: Thomas Urban, Director
On April 7, 2026, the Board of Directors (the "Board") of Cibus, Inc. (the "Company") appointed Thomas Urban to serve as a member of the Board, effective as of such date.
- Mr. Urban, 61, is the founder of Agribusiness Advisors, a firm he formed in 2013 focused on providing advisory, investment and entrepreneur support to early-stage companies focused on agriculture.
- Prior to forming Agribusiness Advisors, Mr. Urban was the chief executive officer of CellFor, Inc. from 2004 to 2012 when it was acquired by ArborGen, served in various leadership positions around the world from 1990 to 2002 with Pioneer Hi-Bred International, including after its acquisition by E.I. DuPont de Nemours in 1999, and began his career in mergers and acquisitions at Goldman, Sachs & Co. in 1988.
- Mr. Urban has also served as an entrepreneur in residence at the University of British Columbia since 2013.
- Mr. Urban received his undergraduate degree from Middlebury College and holds a Master of Business Administration from the Harvard Graduate School of Business.
- Pursuant to the Company's Non-Employee Director Compensation Policy, the Board agreed to provide Mr. Urban with annual compensation comprising (i) a cash retainer equal to $60,000, payable semi-annually, and (ii) subject to Board approval and granting pursuant to the terms and provisions of the Cibus, Inc. 2017 Omnibus Incentive Plan, as amended, equity compensation with a grant date value equal to $90,000.
Tools for this story
Each opens in a new tab, filled in for Cibus, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.